IPR2023-00724
`U.S. Patent 10,335,462
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioners
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2023-00724
`Patent 10,335,462
`______________________
`
`NOTICE OF DEPOSITION OF DR. JOHN BANTLE
`
`
`
`
`U.S. Patent 10,335,462
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioners
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2023-00724
`Patent 10,335,462
`______________________
`
`NOTICE OF DEPOSITION OF DR. JOHN BANTLE
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`Pursuant to 37 C.F.R. §42.53, Patent Owner Novo Nordisk A/S (“Novo”),
`
`by and through its attorneys, will conduct cross-examination by deposition of Dr.
`
`John Bantle. Dr. Bantle’s deposition will take place on July 11, 2024,
`
`commencing at 11:00 CST/10:00 EST, via remote audio-video conference via a
`
`remote platform.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded by using stenographic
`
`means or a digital reporter. Novo further reserves the right to utilize the following:
`
`(1) record the deposition using audio technology; (2) instant visual display such that
`
`the reporter’s writing of the proceeding will be available to all who are a party to
`
`this proceeding to request and receive it in real time; (3) exhibit capture (picture-in-
`
`picture) technology in which any exhibit reviewed by the deponent during the
`
`deposition can be captured visually; and (4) to conduct this deposition using a
`
`paperless exhibit virtual display platform. The arrangement for the reporter will be
`
`made by counsel for Novo.
`
`
`
`
`
`
`
`
`
`
`
`1
`
`
`
`IPR2024-00107
`U.S. Patent 10,335,462
`Dated: June 10, 2024
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`By: /Megan Raymond /
`J. Steven Baughman (Reg. No. 47,414)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5832
`steve.baughman@groombridgewu.com
`
`
`Megan Raymond (Reg. No. 72,997)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5878
`megan.raymond@groombridgewu.com
`
`Attorneys for Patent Owner Novo Nordisk A/S
`
`
`
`
`
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2024-00107
`U.S. Patent 10,335,462
`
`The undersigned hereby certifies that a copy of PATENT OWNER’S
`
`NOTICE OF DEPOSITION OF DR. JOHN BANTLE has been served in its
`
`entirety by causing the aforementioned document to be electronically mailed to the
`
`following attorneys of record for the Petitioners listed below:
`
`Petitioners’ Counsel of Record:
`
`
`
`Lead Counsel
`for Mylan
`Pharmaceuticals,
`Inc.:
`
`Brandon M. White
`Reg. No. 52,354
`White-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Suite 800
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`By Electronic Mail
`Backup Counsel: Emily J. Greb
`Reg. No. 68,244
`Greb-ptab@perkinscoie.com
`Perkins Coie LLP
`33 East Main Street
`Madison, WI 53703
`Telephone: (608) 663-7460
`
`Courtney Prochnow, PhD
`Reg. No. 67,639
`Prochnow-ptab@perkinscoie.com
`Perkins Coie LLP
`633 W. 5th St., Ste 5850
`Los Angeles, CA 90071
`Telephone: (310) 788-9900
`
`Christopher D. Jones
`Reg. No. 76,472
`
`3
`
`
`
`IPR2024-00107
`U.S. Patent 10,335,462
`
`Jones-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Suite 800
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Jonathan I. Tietz, PhD
`Reg. No. 76,753
`Tietz-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Suite 800
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Matthew A. Lembo
`Reg. No. 75,633
`Lembo-ptab@perkinscoie.com
`Perkins Coie LLP
`1155 Avenue of the Americas
`Floor 22
`New York, NY 10036
`Telephone: (212) 262-6900
`
`Shannon M Bloodworth
`(Admitted pro hac vice)
`SBloodworth@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Suite 800
`Washington, DC 20005
`Telephone: (212) 654-6200
`
`David L. Anstaett
`(Admitted pro hac vice)
`DAnstaett@perkinscoie.com
`Perkins Coie LLP
`33 East Main Street
`Madison, WI 53703
`
`4
`
`
`
`IPR2024-00107
`U.S. Patent 10,335,462
`
`Telephone: (608) 663-7460
`
`Bryan D. Beel
`(Admitted pro hac vice)
`BBeel@perkinscoie.com
`Perkins Coie LLP
`1120 NW Couch St.
`10th Floor
`Portland, OR 97209
`Telephone: (503) 727-2000
`
`Nathan Kelley
`Reg. No. 45,295
`Kelly_nathan-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Suite 800
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Rodney Swartz
`Reg. No. 73,343
`RSwartz@perkinscoie.com
`Perkins Coie LLP
`1120 NW Couch St.
`10th Floor
`Portland, OR 97209
`Telephone: (503) 727-2000
`
`Semaglutide-Ozempic@perkinscoie.com
`
`By Electronic Mail
`
`5
`
`
`
`
`
`
`
`
`
`
`
`IPR2024-00107
`U.S. Patent 10,335,462
`
`Lead Counsel
`for Dr. Reddy’s
`Laboratories,
`Inc. and Dr.
`Reddy’s
`Laboratories.
`Ltd.:
`
`Backup
`Counsel:
`
`Jovial Wong
`Reg. No. 60,115
`Winston & Strawn LLP
`1901 L Street NW
`Washington, DC 20036
`Telephone: (202) 282-5867
`jwong@winston.com
`
`By Electronic Mail
`Scott Border
`Reg. No. 77,744
`Winston & Strawn LLP
`1901 L Street NW
`Washington, DC 20036
`Telephone: (202) 285-5054
`sborder@winston.com
`
`Sharon Lin McIntosh
`(pro hac vice to be submitted)
`Winston & Strawn LLP
`1901 L Street NW
`Washington, DC 20036
`Telephone: (202) 285-5756
`slin@winston.com
`
`By Electronic Mail
`
`
`
`
`
`
`
`
`
`6
`
`
`
`IPR2024-00107
`U.S. Patent 10,335,462
`
`Lead Counsel
`for Sun
`Pharmaceutical
`Industries Ltd.
`and Sun
`Pharmaceutical
`Industries, Inc.:
`
`Backup
`Counsel:
`
`Brian Sodikoff
`KATTEN MUNCHIN ROSENMAN LLP
`525 West Monroe Street
`Chicago, IL 60661
`P: (312) 902-5200
`brian.sodikoff@katten.com
`
`By Electronic Mail
`Christopher B. Ferenc
`KATTEN MUNCHIN ROSENMAN LLP
`1919 Pennsylvania Ave., N.W.
`Suite 800
`Washington, DC 20006
`P: (202) 625-3500
`christopher.ferenc@katten.com
`
`By Electronic Mail
`
`
`
`Dated: June 10, 2024
`
`
`
`
`
`
`
` Respectfully submitted,
`By: /Sayem Osman/
`Sayem Osman
`
`7
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
